Liraglutide versus exenatide: which is the superior drug?

摘要

Type 2 diabetics are sometimes prescribed glucagon-like peptide-1 receptor agonists in order to improve their glycemic control while decreasing body weight. Such drugs include exenatide and liraglutide. To determine the safety and efficacy of these drugs, Guntram Schernthaner (Rudolfstiftung Hospital, Vienna, Austria) and colleagues conducted a study aimed at comparing the impact of once-daily liraglutide with once-weekly exenatide in individuals with Type 2 diabetes.